Solara Active Pharma Sciences (NSE:SOLARA) Accounts Receivable : ₹3,266 Mil (As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Solara Active Pharma Sciences's accounts receivables for the quarter that ended in Mar. 2025 was ₹3,266 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Solara Active Pharma Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2025 was 109.15.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Solara Active Pharma Sciences's Net-Net Working Capital per share for the quarter that ended in Mar. 2025 was ₹-149.26.

Solara Active Pharma Sciences Accounts Receivable Historical Data

The historical data trend for Solara Active Pharma Sciences's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Accounts Receivable Chart

Solara Active Pharma Sciences Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Accounts Receivable

Get a 7-Day Free Trial

4,838.70

4,896.70

5,369.90

3,485.20

3,265.70

Solara Active Pharma Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Receivable	Get a 7-Day Free Trial															3,485.20	-	3,838.70	-	3,265.70

Solara Active Pharma Sciences Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Solara Active Pharma Sciences Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Solara Active Pharma Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	3265.7	/	2730.1	*	91
=	109.15

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Solara Active Pharma Sciences's accounts receivable are only considered to be worth 75% of book value:

Solara Active Pharma Sciences's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2025 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(164.7	+	0.75 * 3265.7	+	0.5 * 3179	-	11349.3
-	0	-	26.7)	/	48.053
=	-149.26

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Solara Active Pharma Sciences Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Solara Active Pharma Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (NSE:SOLARA) » Definitions » Accounts Receivable

Traded in Other Exchanges

SOLARAPP1:India 890202:India 541540:India

Address

27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127

Website

https://www.solara.co.in

Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines